GenoFocus Inc (187420) — Cash Flow Quality Index
Latest as of December 2025:
0.03x
GenoFocus Inc (187420) has a Cash Flow Quality Index of 0.03x as of December 2025. Operating cash flow of ₩288.09 Million is below net income of ₩9.06 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore GenoFocus Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
0.03x
Operating CF / Net Income
Operating Cash Flow
₩288.09 Million
KRW
Net Income
₩9.06 Billion
KRW
Data as of
Dec 2025
Most recent filing
GenoFocus Inc Cash Flow Quality Index (2014–2025)
Historical Cash Flow Quality Index for GenoFocus Inc across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 187420 cash flow metrics.
Annual Cash Flow Quality Index for GenoFocus Inc (2014–2025)
Year-by-year earnings quality comparison for GenoFocus Inc.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | ₩3.50 Billion | ₩22.59 Billion | ▼ -84.0% |
| 2017 | 0.97x | ₩1.36 Billion | ₩1.41 Billion | ▲ +202.5% |
| 2016 | 0.32x | ₩516.09 Million | ₩1.61 Billion | ▼ -86.4% |
| 2015 | 2.36x | ₩2.85 Billion | ₩1.21 Billion | ▲ +1894.5% |
| 2014 | -0.13x | ₩-286.45 Million | ₩2.18 Billion | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.